These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Evaluation of larvicidal effects of Bacillus thuringiensis var. israelensis (serotype H-14) and Bacillus sphaericus preparations and the susceptibility of adult mosquitoes to malarial plasmodia]. Ganushkina LA Med Parazitol (Mosk); 1987; (1):10-3. PubMed ID: 3553885 [No Abstract] [Full Text] [Related]
23. Application of different downstream processing methods and their comparison for the large-scale preparation of Bacillus thuringiensis var. israelensis after fermentation for mosquito control. Prabakaran G; Hoti SL Biologicals; 2008 Nov; 36(6):412-5. PubMed ID: 18657445 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of granular corncob formulations of Bacillus thuringiensis serovar israelensis against mosquito larvae using a semi-field bioassay method. Ali A; Xue RD; Lobinske R; Carandang N J Am Mosq Control Assoc; 1994 Dec; 10(4):492-5. PubMed ID: 7707052 [TBL] [Abstract][Full Text] [Related]
25. [The efficacy of a combined preparation based on Bacillus sphaericus and Bac. thuringiensis H-14 against the larvae of blood-sucking mosquitoes]. Chabanenko AA; Bogdanova EN; Ermishev IuV; Dremova VP Med Parazitol (Mosk); 1992; (1):23-5. PubMed ID: 1354836 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of the present dengue situation and control strategies against Aedes aegypti in Cebu City, Philippines. Mahilum MM; Ludwig M; Madon MB; Becker N J Vector Ecol; 2005 Dec; 30(2):277-83. PubMed ID: 16599163 [TBL] [Abstract][Full Text] [Related]
27. Comparative delta-endotoxins of Bacillus thuringiensis against mosquito vectors (Aedes aegypti and Culex pipiens). Lonc E; Kucińska J; Rydzanicz K Acta Microbiol Pol; 2003; 52(3):293-300. PubMed ID: 14743982 [TBL] [Abstract][Full Text] [Related]
28. [Characteristics of Bacillus thuringiensis var. israelensis and its effect on mosquito larvae (Diptera: Culicidae)]. Müller P Angew Parasitol; 1984 Aug; 25(3):157-63. PubMed ID: 6149708 [No Abstract] [Full Text] [Related]
29. Preliminary field evaluation of the combined adulticidal, larvicidal, and wall residual activity of ULV-applied bifenthrin against mosquitoes. Lee HL; Khadri MS; Chiang YF J Vector Ecol; 1997 Dec; 22(2):146-9. PubMed ID: 9491365 [TBL] [Abstract][Full Text] [Related]
30. Indoor thermal fogging against vector mosquitoes with two Bacillus thuringiensis israelensis formulations, Vectobac ABG 6511 water-dispersible granules and Vectobac 12AS liquid. Yap HH; Lee YW; Zairi J J Am Mosq Control Assoc; 2002 Mar; 18(1):52-6. PubMed ID: 11998931 [TBL] [Abstract][Full Text] [Related]
31. Laboratory evaluation of biotic and abiotic factors that may influence larvicidal activity of Bacillus thuringiensis serovar. israelensis against two Florida mosquito species. Nayar JK; Knight JW; Ali A; Carlson DB; O'Bryan PD J Am Mosq Control Assoc; 1999 Mar; 15(1):32-42. PubMed ID: 10342266 [TBL] [Abstract][Full Text] [Related]
32. Microbial control of mosquitoes with special emphasis on bacterial control. Bhattacharya PR Indian J Malariol; 1998 Dec; 35(4):206-24. PubMed ID: 10748561 [TBL] [Abstract][Full Text] [Related]
33. Integration of Bacillus thuringiensis H-14 formulations and pyriproxyfen for the control of larvae of Aedes aegypti and Aedes albopictus. Lee YW; Zairi J; Yap HH; Adanan CR J Am Mosq Control Assoc; 2005 Mar; 21(1):84-9. PubMed ID: 15825767 [TBL] [Abstract][Full Text] [Related]
34. Combination of Mesocyclops thermocyclopoides and Bacillus thuringiensis var. israelensis: a better approach for the control of Aedes aegypti larvae in water containers. Chansang UR; Bhumiratana A; Kittayapong P J Vector Ecol; 2004 Dec; 29(2):218-26. PubMed ID: 15707281 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of new formulations of the microbial larvicide Bacillus sphaericus against polluted water mosquitoes in Thailand. Mulla MS; Su T; Thavara U; Tawatsin A; Ngamsuk W; Pan-Urai P J Vector Ecol; 1999 Jun; 24(1):99-110. PubMed ID: 10436884 [TBL] [Abstract][Full Text] [Related]
36. Factors influencing the activity of Bacillus thuringiensis var. israelensis treatments. Becker N; Zgomba M; Ludwig M; Petric D; Rettich F J Am Mosq Control Assoc; 1992 Sep; 8(3):285-9. PubMed ID: 1357088 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of Arosurf MSF and formulations of Bacillus thuringiensis var. israelensis against Anopheles albimanus: laboratory bioassay. Perich MJ; Rogers JT; Boobar LR J Am Mosq Control Assoc; 1987 Sep; 3(3):485-8. PubMed ID: 3504934 [TBL] [Abstract][Full Text] [Related]
38. A new serovar of Bacillus thuringiensis possessing 28a28c flagellar antigenic structure: Bacillus thuringiensis serovar jegathesan, selectively toxic against mosquito larvae. Seleena P; Lee HL; Lecadet MM J Am Mosq Control Assoc; 1995 Dec; 11(4):471-3. PubMed ID: 8825511 [TBL] [Abstract][Full Text] [Related]
39. Field evaluation of Bacillus thuringiensis H-14 against Aedes mosquitoes. Lee YW; Zairi J Trop Biomed; 2006 Jun; 23(1):37-44. PubMed ID: 17041550 [TBL] [Abstract][Full Text] [Related]
40. Field trials of three concentrations of Laginex as biological larvicide compared to Vectobac-12AS as a biocontrol agent for Culex quinquefasciatus. Hallmon CF; Schreiber ET; Vo T; Bloomquist A J Am Mosq Control Assoc; 2000 Mar; 16(1):5-8. PubMed ID: 10757483 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]